ArthroCare to Host Conference Call on February 14, 2013

Mon Feb 11, 2013 4:27pm EST

* Reuters is not responsible for the content in this press release.

AUSTIN, Texas--(Business Wire)--
ArthroCare Corporation (NASDAQ: ARTC), a leader in developing state-of-the-art,
minimally invasive surgical products, plans to release its fourth quarter and
year end 2012 results on Thursday, February 14, 2013. 

ArthroCare will host a conference call on Thursday, February 14, 2013 at 8:30
a.m. ET to discuss the Company`s operating results. A press release summarizing
the results will be made available after market on Wednesday, February 13, 2013.
To participate in the live conference call dial 800-763-5654. A live and
on-demand webcast of the call will be available on ArthroCare`s Web site at A telephonic replay of the conference call can be accessed
by dialing 800-633-8284 and entering pass code number 21648357. The replay will
remain available through February 28, 2013. 


ArthroCare develops and manufactures surgical devices, instruments, and implants
that strive to enhance surgical techniques as well as improve patient outcomes.
Its devices improve many existing surgical procedures and enable new minimally
invasive procedures. Many of ArthroCare`s devices use its internationally
patented CoblationĀ® technology. This technology precisely dissolves target
tissue and limits damage to surrounding healthy tissue. ArthroCare also develops
surgical devices utilizing other patented technology including its OPUSĀ® line of
fixation products as well as re-usable surgical instruments. ArthroCare is
leveraging these technologies in order to offer a comprehensive line of surgical
devices to capitalize on a multi-billion dollar market opportunity across
several surgical specialties, including its two core product areas consisting of
Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine,
wound care, urology and gynecology. 


The information provided herein includes forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as amended.
Statements that are not historical facts are forward-looking statements.
Forward-looking statements are based on beliefs and assumptions by management
and on information currently available to management. Forward-looking statements
speak only as of the date they are made, and the Company undertakes no
obligation to update any of them publicly in light of new information or future
events. Additional factors that could cause actual results to differ materially
from those contained in any forward-looking statement include, without
limitation: the resolution of litigation pending against the Company; the impact
upon the Company`s operations of legal compliance matters which may require
improvement and remediation; the ability of the Company to control expenses
relating to legal or compliance matters; the Company`s ability to remain current
in its periodic reporting requirements under the Exchange Act and to file
required reports with the Securities and Exchange Commission on a timely basis;
the results of the investigation being conducted by the United States Department
of Justice; the impact on the Company of additional civil and criminal
investigations by state and federal agencies and civil suits by private third
parties involving the Company`s financial reporting and its previously announced
restatement and its insurance billing and healthcare fraud-and-abuse compliance
practices; the results of the civil investigation by the Department of Justice
related to the Civil Investigative Demand we received arising under the False
Claims Act; the possibility that the Department of Justice could institute civil
proceedings against us, based on the results of the investigation related to the
Civil Investigative Demand; the risk that we could be subject to qui tam suits
involving the False Claims Act; the possibility that the Department of Justice
could institute a criminal enforcement action against us based on the results of
the civil investigation related to the Civil Investigative Demand;the resolution
of any litigation related to the civil investigation; the ability of the Company
to attract and retain qualified senior management and to prepare and implement
appropriate succession planning for its Chief Executive Officer; general
business, economic and political conditions; competitive developments in the
medical devices market; changes in applicable legislative or regulatory
requirements; the Company`s ability to effectively and successfully implement
its business strategies, and manage the risks in its business; and the reactions
of the marketplace to the foregoing.

ArthroCare Corp.
Misty Romines, 512-391-3902 

Copyright Business Wire 2013

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.